InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Explore the full record of transactions filed by Gould Robert J, Director. Officer active across 1 companies, notably Fulcrum Therapeutics, Inc.. Aggregated, 10 disclosures have been published. Total volume traded: €852k. The latest transaction was disclosed on 2 February 2026 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations10 total
US$138,79415,000 shares@ US$9.25290.031% mcap32.6% of flow
Common Stock
SEC:0001193125-26-037606·
US$135,75415,000 shares@ US$9.05020.030% mcap31.9% of flow
Common Stock
SEC:0001193125-26-037573·
€138,79415,000 shares@ €9.25290.031% mcap7.8% of flow
Common Stock
SEC:0001193125-26-037606:0·
€135,75415,000 shares@ €9.05020.030% mcap7.6% of flow
Common Stock
SEC:0001193125-26-037573:0·
US$151,55915,000 shares@ US$10.10390.034% mcap35.6% of flow
Common Stock
SEC:0001193125-26-004572·
€151,55915,000 shares@ €10.10390.034% mcap8.5% of flow
Common Stock
SEC:0001193125-26-004572:0·
€523,47971,435 shares@ €7.3280.12% mcap29.4% of flow
Common Stock
SEC:0000899243-22-021530:0·
€121,70116,689 shares@ €7.29230.027% mcap6.8% of flow
Common Stock
SEC:0000899243-22-021250:0·
€40,6335,631 shares@ €7.21590.0091% mcap2.3% of flow
Common Stock
SEC:0000899243-22-014438:0·
€244,02934,464 shares@ €7.08070.055% mcap13.7% of flow
Common Stock
SEC:0000899243-22-013881:0·
10 of 10 declarations
About Gould Robert J
Robert J. Gould is a Director at Fulcrum Therapeutics, Inc. He contributes to the governance of the company and strategic decision-making. Robert brings his expertise in biotechnology to help Fulcrum innovate and grow in the market.
